Creating a premier oncology biotech company in Europe

Carrick Therapeutics is collaborating with a network of researchers and partners to build an innovative portfolio of first-in-class treatments that target multiple mechanisms of the most aggressive forms of cancer.

Go to the profile of Carrick Therapeutics
Mar 09, 2018
1
0
Page of
Go to the profile of Carrick Therapeutics

Carrick Therapeutics

Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an individual patient’s tumour. Targeting the molecular pathways that drive the most aggressive and resistant forms of cancer will transform the way that cancer is treated and have a major impact on the lives of cancer patients. By linking a network of clinicians and scientists in internationally leading research institutes and hospitals, Carrick will streamline the introduction of these ground-breaking cancer therapies into the clinic, thus serving cancer patients around the world.

No comments yet.